Clinical Trial

Post Market Clinical Follow Up of LEGION™ Primary TKS With VERILAST™

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
LEGION™ Primary Total Knee System is CE-marked and marketed in all study regions. This study serves as post-market surveillance for LEGION™ Primary Total Knee System with the VERILAST™ bearing surface (OXINIUM™ femoral component with highly cross-linked polyethylene tibial insert). All study subjects will receive a LEGION™ Primary Total Knee System with VERILAST™ bearing surface and the results will be analysed against historical data from patients who received a Genesis II knee replacement.
Protocol Amendment History 24 amendments
This ClinicalTrials.gov record has been amended 24 times since 2015-03-04; most recent amendment 2025-12-05.
Status change: Recruiting → Active, Not Recruiting 2020-02-05
Status change: Not Yet Recruiting → Recruiting 2015-11-17
Trial Details
NCT Number NCT02380092
Lead Sponsor Smith & Nephew, Inc.
Conditions Degenerative Joint Disease
Enrollment 163 participants
Start Date 2015-09
Primary Completion 2029-05 (estimated)
Study Completion 2029-05 (estimated)
Updated on ClinicalTrials.gov 2025-12-15